CASEY JENSEN: Open Payments
NPI 1326560087 · SHELBYVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$830 in 49 payments from 17 companies in 2025. Trend: 2023 $967 · 2024 $1,490 · 2025 $830
Food & beverage: $830
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $163 |
| Vanda Pharmaceuticals Inc. | 5 | $132 |
| Novo Nordisk Inc | 4 | $60 |
| Amgen Inc. | 4 | $57 |
| Otsuka America Pharmaceutical, Inc. | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
| PFIZER INC. | 3 | $54 |
| Lilly USA, LLC | 3 | $51 |
| Phathom Pharmaceuticals, Inc. | 4 | $37 |
| Janssen Pharmaceuticals, Inc | 1 | $31 |
Products named: HETLIOZ, VRAYLAR, REXULTI, Ozempic, OTEZLA, CAPLYTA, PREVNAR 20, UBRELVY.
Industry payments across KY — which companies pay providers there.
